Ruth E. Tyler-Cross, Ph.D., is a patent agent and technical advisor of the firm. With nearly 20 years of patent prosecution experience, Dr. Tyler-Cross has obtained numerous patents related to DNA, new pharmaceuticals, and medical treatments for the firm’s clients. Her areas of expertise include peptide, protein and carbohydrate chemistry, as well as molecular biology. Dr. Tyler-Cross has extensive experience with techniques involving protein isolation and characterization, peptide synthesis and analysis, rational drug design and the investigation of genetic regulation.
Dr. Tyler-Cross has a Ph.D. in Biochemistry and Molecular Biophysics from the Virginia Commonwealth University in Richmond and a B.S. in Microbiology and Immunology from the University of Washington in Seattle. Dr. Tyler-Cross is registered to practice before the U.S. Patent and Trademark Office and is a member of the American Chemical Society.
Jackie Reed, PhD, is a molecular biologist and registered patent agent of the firm. She has over a decade of intellectual property management experience in industry and academia. She has extensive experience in the areas of biotechnology, medicine, and medical devices, with expertise encompassing recombinant DNA and RNA techniques, design and analysis of transgenic mice, gene regulation, translational medicine, and clinical laboratory medicine. Her post-doctoral research included studies of cytokine signaling and regulation of metabolic processes in pulmonary, adipose, and neuronal cells.
Dr. Reed earned her PhD in Molecular Developmental Biology at the University of Cincinnati College of Medicine, BS in Natural Sciences at the University of Cincinnati, and AS in Medical Laboratory Technology at Indiana Wesleyan University. She was a co-founder and intellectual property manager during the early days of the biotech start-up now known as Intrexon Corporation. She studied patent law coursework at the University of Cincinnati College of Law as a non-matriculated student before relocating to Virginia to work as a licensing associate at Virginia Tech Intellectual Property (VTIP), where she managed a portfolio of life science, medical device, and pharmaceutical invention disclosures and patents.
Dou Yeon Youn, Ph.D., is a molecular pharmacologist and registered patent agent of the firm. She has extensive research experience in the areas of pharmacology, biotechnology, in vivo and in vitro molecular biology, synthetic chemistry, enzymology and biochemistry. Her doctoral research included small molecule drug development and study of enzyme activities that are associated with aging and metabolic disorders. Her post-doctoral research included studies in transcriptional gene regulation in fatty liver disease with next generation sequencing and single cell analysis.
Dr. Youn earned her PhD in Pharmacology at Weill Medical College of Cornell University and her BS in Pharmacology at the State University of New York at Stony Brook. She was trained as a postdoctoral fellow at Columbia University under New York Nutritional Obesity Research Center and also at Einstein-Mount Sinai Diabetes Research Center, where she worked as a research faculty before joining the firm. Dr. Youn is originally from Busan, South Korea. Dr. Youn is registered to practice before the U.S. Patent and Trademark Office.